ACP

Acuta Capital Partners Portfolio holdings

AUM $71.6M
This Quarter Return
-9.19%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$210M
AUM Growth
+$210M
Cap. Flow
+$4.88M
Cap. Flow %
2.32%
Top 10 Hldgs %
61.11%
Holding
46
New
9
Increased
9
Reduced
9
Closed
7

Top Buys

1
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
$4.66M
2
AVDL
Avadel Pharmaceuticals
AVDL
$3.96M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.49M
4
KURA icon
Kura Oncology
KURA
$2.93M
5
PMVP icon
PMV Pharmaceuticals
PMVP
$2.82M

Top Sells

1
CYT
Cyteir Therapeutics, Inc. Common Stock
CYT
$4.46M
2
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
$3.19M
3
ATHA icon
Athira Pharma
ATHA
$2.29M
4
ALDX icon
Aldeyra Therapeutics
ALDX
$2M
5
PYXS icon
Pyxis Oncology
PYXS
$1.93M

Sector Composition

1 Healthcare 93.41%
2 Financials 6.59%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
APLS icon
1
Apellis Pharmaceuticals
APLS
$3.48B
$28.1M 13.15% 554,000 +19,000 +4% +$965K
WHWK
2
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.1M
$26M 12.13% 1,529,402 – –
VTGN icon
3
VistaGen Therapeutics
VTGN
$102M
$14.6M 6.8% 11,736,283 – –
CLDX icon
4
Celldex Therapeutics
CLDX
$1.47B
$11M 5.14% 322,898 -17,200 -5% -$586K
RLMD icon
5
Relmada Therapeutics
RLMD
$37.2M
$9.23M 4.31% 342,000 -62,000 -15% -$1.67M
ISEE
6
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$9.08M 4.24% 539,500 +69,500 +15% +$1.17M
BLSA
7
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$8.32M 3.89% 843,122 – –
GHRS icon
8
GH Research
GHRS
$837M
$7.68M 3.59% 419,632 – –
KURA icon
9
Kura Oncology
KURA
$686M
$7.62M 3.56% 473,969 +182,085 +62% +$2.93M
XENE icon
10
Xenon Pharmaceuticals
XENE
$2.98B
$6.88M 3.21% 225,000 – –
VRDN icon
11
Viridian Therapeutics
VRDN
$1.5B
$6.29M 2.94% 340,000 +22,000 +7% +$407K
MRUS icon
12
Merus
MRUS
$4.98B
$6.23M 2.91% 235,500 – –
BLU
13
DELISTED
BELLUS Health Inc.
BLU
$5.61M 2.62% 816,000 +291,000 +55% +$2M
JNCE
14
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$5.52M 2.58% 813,500 +686,000 +538% +$4.66M
JYAC
15
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$5.52M 2.58% 562,500 – –
FULC icon
16
Fulcrum Therapeutics
FULC
$351M
$4.73M 2.21% 200,000 – –
MRTX
17
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$4.32M 2.02% 52,500 +32,500 +163% +$2.67M
AVDL
18
Avadel Pharmaceuticals
AVDL
$1.43B
$3.96M 1.85% +580,000 New +$3.96M
OBIO icon
19
Orchestra BioMed
OBIO
$147M
$3.89M 1.82% 392,500 – –
ARWR icon
20
Arrowhead Research
ARWR
$3.05B
$3.79M 1.77% 82,500 -23,000 -22% -$1.06M
ACRS icon
21
Aclaris Therapeutics
ACRS
$209M
$3.75M 1.75% 217,600 +119,600 +122% +$2.06M
EYPT icon
22
EyePoint Pharmaceuticals
EYPT
$797M
$3.74M 1.75% 307,944 +64,872 +27% +$788K
SNDX icon
23
Syndax Pharmaceuticals
SNDX
$1.41B
$3.58M 1.67% 206,126 – –
HZNP
24
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.49M 1.63% +33,200 New +$3.49M
PMVP icon
25
PMV Pharmaceuticals
PMVP
$74.2M
$2.82M 1.32% +135,500 New +$2.82M
1
2